Cargando…
The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia
The oncogenic transcription factor TAL1/SCL is aberrantly expressed in 60% of cases of human T cell acute lymphoblastic leukemia (T-ALL) and initiates T-ALL in mouse models. By performing global microRNA (miRNA) expression profiling after depletion of TAL1, together with genome-wide analysis of TAL1...
Autores principales: | Mansour, Marc R., Sanda, Takaomi, Lawton, Lee N., Li, Xiaoyu, Kreslavsky, Taras, Novina, Carl D., Brand, Marjorie, Gutierrez, Alejandro, Kelliher, Michelle A., Jamieson, Catriona H.M., von Boehmer, Harald, Young, Richard A., Look, A. Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Rockefeller University Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727321/ https://www.ncbi.nlm.nih.gov/pubmed/23857984 http://dx.doi.org/10.1084/jem.20122516 |
Ejemplares similares
-
Repression of tumor suppressor miR-451 is essential for NOTCH1-induced oncogenesis in T-ALL
por: Li, Xiaoyu, et al.
Publicado: (2011) -
PLZF Controls the Expression of a Limited Number of Genes Essential for NKT Cell Function
por: Gleimer, Michael, et al.
Publicado: (2012) -
Targeting dual oncogenic machineries driven by TAL1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia
por: Lim, Fang Qi, et al.
Publicado: (2022) -
MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia
por: Sun, Hongbo, et al.
Publicado: (2020) -
UTX inhibition as selective epigenetic therapy against TAL1-driven T-cell acute lymphoblastic leukemia
por: Benyoucef, Aissa, et al.
Publicado: (2016)